Navigation Links
So-called 'sandfish' could help materials handling and process technology specialists
Date:10/3/2008

It moves as quickly in sand as a fish moves through water, which is why this lizard, a species of skink (Scincus scincus) that grows to about 15 cm long and lives in the deserts of North Africa and the Near East, is commonly known by the name "sandfish."Although it looks fairly unremarkable, this desert animal has a thing or two to teach materials-handling and process-technology specialists,as it spends most of its time below the surface of the sand and moves through its element extremely efficiently,and scientists hope to apply the insights they gain from nature to improve industrial technologies for the handling of granular materials.Whether it's gravel, sand or flour, optimising the technology for handling such materials could significantly reduce energy and maintenance costs for businesses such as quarries and industrial bakeries in the future.

In a new article published in the journal PLoS ONE, Prof. Werner Baumgartner and colleagues from the Department of Cellular Neurobionics at RWTH Aachen used an MRI scanner to observe the sandfish as it "swims" through the sand.

"We took a round container that would fit snugly into the MRI and filled it with sand," says Prof. BaumgartnerBaumgartner.The project, which was carried out in collaboration with researchers from the University of Wrzburg and Museum Knig in Bonn, has provided a visual record of the animal's movements in the sand as viewed from above and from the side.

The scientists found the results highly surprising:until now, it was thought that the sandfish pulled its legs in against its body, but the experiments revealed that it actually moves its legs back and forth in a fixed pattern."This seems illogical at first, because sand provides resistance," says Baumgartner."But we found out that its leg movements are very well coordinated with the wriggling of its body."

It turns out that the sandfish moves in a way very similar to the crawl stroke in swimming.
'/>"/>

Contact: Professor Werner Baumgartner
werner@bio2.rwth-aachen.de
Public Library of Science
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Newly created cancer stem cells could aid breast cancer research
2. Obesity and lack of exercise could enhance the risk of pancreatic cancer
3. Finding that 1-in-a-billion that could lead to disease
4. 60 second test could help early diagnosis of common brain diseases
5. Auto immune response creates barrier to fertility; could be a step in speciation
6. Paracetamol, one of most used analgesics, could slow down bone growth
7. Drug could improve pregnancy outcomes in wider range of women with insulin resistance
8. Thousands of starving children could be restored to health with peanut butter program
9. Nanotech could make solar energy as easy and cheap as growing grass
10. CO2 emissions could violate EPA ocean-quality standards within decades
11. MIT model could improve some drugs effectiveness

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...ass., Oct. 20 Aware, Inc...d technology and biometrics software, today report...September 30, 2009. ,, Michael Tzannes, Aware...rlier today, we announced an agreement to sell our...a new fabless semiconductor company being spun out...
(Date:11/4/2009)..., Oct. 26 BIO-key Intern... in finger-based biometric identification software...s at the AABB TXPO conference being held at the Ne...9. BIO-key will provide hands-on product demonstra...ology in booth #424. Also, at 5 PM on Monday, Octo...
(Date:11/4/2009)...Calif., Nov. 4 GenVault Corporatio...y, M.D., Ph.D., has joined its Board of Directors....f the Salk Institute, is an acclaimed physician-sc...he Salk Institute, Dr. Brody served as president o... the National Academy of Engineering and the Insti...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7BIO-key(R) International Exhibiting at AABB TXPO 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Susies Big Adventure Explores Plastic Surgery In Saudi Arabia 53959 1Beetroot Juice May Boost Stamina 53957 1Beetroot Juice May Boost Stamina 53957 2School Closures May Not Be Necessary When Swine Flu Strikes 53955 1School Closures May Not Be Necessary When Swine Flu Strikes 53955 2School Closures May Not Be Necessary When Swine Flu Strikes 53955 3School Closures May Not Be Necessary When Swine Flu Strikes 53955 4
..., Mass. (Oct. 20, 2008) -- Two teams of scientists...echnology (HST) at Brigham and Women,s Hospital ha...elivery system that is biocompatible, efficient at...ese structures can deliver clinically approved dru...rs for the drug or generating toxic components, a ...
...chers are on the verge of unleashing the power of ... therapies, as decades of research begins to bear ... best kept secrets, but is now attracting fast gro...rmaceutical industry in the quest for novel drugs ...lly overcoming limitations and side effects of cur...
...thers purposely expose their offspring to their ow...use it is widely accepted that exposure to materna...ative impacts on offspring following birth. To exa...pen, evolutionary physiologists Oliver Love and To... maternally-derived stress hormone corticosterone ...
Other Biology News:European researchers harness unique properties of boron to develop new drugs and diagnostics 2European researchers harness unique properties of boron to develop new drugs and diagnostics 3Exposing chicks to maternal stress leads to long-term reproductive success 2
(Date:11/6/2009)..., Nov. 6 BioSpecifics Te...ical company developing first-in-class collagenase...ults for the third quarter ended September 30, 200...ber of this year, the FDA,s Arthritis Advisory Com... the approval of XIAFLEX(TM) for the treatment of ...
(Date:11/6/2009)...stria, November 6 EUCODIS Bioscien...ng, and marketing enzymes for the,chemical industr...rch,agreement with Bio Sidus, the leading biopharm... agreement gives EUCODIS Bioscience exclusive acce...o Sidus, proprietary collection of,psychrophilic b...
(Date:11/6/2009)...6 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc....any") today announced updated results from a Phase...ith sarcomas metastatic to the lung in a poster pr...cology Society Meeting held in Miami Beach, Florid...on, entitled "A Phase II Study of Intravenous REOL...
(Date:11/5/2009)...-- Gone hybrid . . . , Fuel economy ratings fo...ed at the www.fueleconomy.gov web site, which Oa...s for the U.S. Department of Energy and the U.S. E... vehicles on the best fuel economy list are hybrid...48 highway). "This list proves that hybrids have g...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
...iences Inc. today announced the development of a u...g from tissue hydration to the passivation of medi...is a series of patent-pending polymers that allow ... angle," says Andrew Loxley, PS, Director of New T...ed the system to develop an ocular formulation for...
...chnology today announced,that the company has obta...utilize Merck Eprova,s proprietary chiral lipid DO...ts in development based on the Versamune(TM),techn...oride shows enhanced,adjuvant activity compared to...enantiomerically pure DOTAP Chloride manufactured ...
...ork Sciences, Inc. (GNS) today announced that it h...Executive Officer of Stromedix, Inc. and former Ex... to its Board of Directors. , , Dr. Gilman has ...dix since June 2006. He was previously Executive ... Biogen in 1999 as Director of Molecular Biology a...
Other Biology Technology:Particle Sciences Completes Development of First Product Incorporating its Unique Surface Modification System 2PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprova's Enantiomers of DOTAP Chloride in Immunotherapies 2Gene Network Sciences Announces Michael Gilman as Board Member 2
Rabbit Anti-CRIPT Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
...quadrupole 1200L sets the new standard for value i...ng the latest technologies and providing tailored ... needs. The Atmospheric Pressure Ionization (API)...r provide superior selectivity and sensitivity for...
Goat Anti-Human Legumain Polyclonal Antibodies, from R&D Systems
Rat Anti-Mouse Endoglin Monoclonal Antibody, Fluorescein Conjugated, Clone 209701 from R&D Systems
Biology Products: